The Enterprise Value as of December 2025 (TTM) for Sarepta Therapeutics, Inc. (0L35.L) is 2.75B

According to Sarepta Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 2.75B. This represents a change of -54.81% compared to the average of 6.08B of the last 4 quarters.

Sarepta Therapeutics, Inc. (0L35.L) Historical Enterprise Value (quarterly & annually)

How has 0L35.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Sarepta Therapeutics, Inc. over the last ten years is 7.55B. The current 2.75B Enterprise Value has changed 3.54% with respect to the historical average. Over the past ten years (40 quarters), 0L35.L's Enterprise Value was at its highest in in the June 2024 quarter at 15.82B. The Enterprise Value was at its lowest in in the June 2016 quarter at 788.46M.

Sarepta Therapeutics, Inc. (0L35.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sarepta Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sarepta Therapeutics, Inc. (0L35.L) Average Enterprise Value

How has 0L35.L Enterprise Value performed in the past?

The current Enterprise Value of Sarepta Therapeutics, Inc. (0L35.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Sarepta Therapeutics, Inc. (0L35.L) Enterprise Value vs. Peers

How is 0L35.L’s Enterprise Value compared to its peers?

Sarepta Therapeutics, Inc.’s Enterprise Value is greater than Agios Pharmaceuticals, Inc. (1.54B), less than Amicus Therapeutics, Inc. (3.51B), greater than Perrigo Company plc (1.41B), less than DENTSPLY SIRONA Inc. (4.43B), greater than uniQure N.V. (525.12M), greater than Intellia Therapeutics, Inc. (850.28M), greater than Viridian Therapeutics, Inc. (2.53B), greater than Supernus Pharmaceuticals, Inc. (-117308365171.00), greater than OPKO Health, Inc. (1.04B), greater than Xeris Biopharma Holdings, Inc. (1.39B),

Build a custom stock screener for Sarepta Therapeutics, Inc. (0L35.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sarepta Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sarepta Therapeutics, Inc. (0L35.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sarepta Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.